Infocom And KNIME GmbH Jointly Develop Modules for Drug Development Technology
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Infocom Corp, a system developer for pharmaceutical research facilities, has signed a licensing agreement with the German firm KNIME GmbH for developing and marketing business computer processing modules based on KNIME, a work flow platform designed to assist drug development research. KNIME, developed by Konstanz University in Germany, is an open system platform which is customizable for different modules and systems. Additionally, Infocom's licensing agreements with Hungarian company ChemAxon and KNIME have allowed it to develop the cheminformatics program suite JChem Node Extension, expected to launch in February 2008. (Click here for more-Japanese language